CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma.

Translated title of the contribution: CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma.

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma.
Original language	Undefined/Unknown
Pages (from-to)	251-259
Number of pages	9
Journal	Netherlands Journal of Medicine
Volume	67
Issue number	7
Publication status	Published - 2009

Cite this

@article{0ac6d2a3e0614d8fb7b1c04d9e600527,

title = "CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma.",

author = "\{van Meerten\}, T. and A. Hagenbeek",

year = "2009",

language = "Undefined/Unknown",

volume = "67",

pages = "251--259",

journal = "Netherlands Journal of Medicine",

issn = "0300-2977",

publisher = "Van Zuiden Communications BV",

number = "7",

}